Gisella Vischini

668 total citations
36 papers, 379 citations indexed

About

Gisella Vischini is a scholar working on Nephrology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Gisella Vischini has authored 36 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 8 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Gisella Vischini's work include Renal Diseases and Glomerulopathies (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). Gisella Vischini is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). Gisella Vischini collaborates with scholars based in Italy, United States and Germany. Gisella Vischini's co-authors include Cristiana Rollino, Rosanna Coppo, Valentina Masola, Antonio Lupo, Giovanni Gambaro, Gloria Bellin, Gianluigi Zaza, Maurizio Onisto, Michele Ferrannini and Laura Scaramucci and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Gisella Vischini

32 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gisella Vischini Italy 10 127 94 56 54 53 36 379
Ioannis Petrakis Greece 13 231 1.8× 126 1.3× 14 0.3× 58 1.1× 67 1.3× 43 506
G. Wild United Kingdom 12 89 0.7× 29 0.3× 13 0.2× 123 2.3× 22 0.4× 23 474
Jakub Kucharz Poland 12 51 0.4× 129 1.4× 7 0.1× 39 0.7× 173 3.3× 47 575
Kinga Musiał Poland 13 208 1.6× 117 1.2× 32 0.6× 64 1.2× 53 1.0× 59 488
Gopalakrishnan Venkat‐Raman United Kingdom 10 321 2.5× 152 1.6× 14 0.3× 13 0.2× 122 2.3× 18 520
Eujin Park South Korea 14 224 1.8× 227 2.4× 13 0.2× 40 0.7× 76 1.4× 61 575
Deborah Kees‐Folts United States 10 224 1.8× 174 1.9× 14 0.3× 82 1.5× 118 2.2× 16 624
Paul Trevillian Australia 13 125 1.0× 59 0.6× 13 0.2× 49 0.9× 82 1.5× 48 514
Takeshi Fujita Japan 12 86 0.7× 97 1.0× 8 0.1× 83 1.5× 68 1.3× 47 421
Yıldız Okuturlar Türkiye 13 48 0.4× 103 1.1× 15 0.3× 38 0.7× 70 1.3× 55 475

Countries citing papers authored by Gisella Vischini

Since Specialization
Citations

This map shows the geographic impact of Gisella Vischini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisella Vischini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisella Vischini more than expected).

Fields of papers citing papers by Gisella Vischini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisella Vischini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisella Vischini. The network helps show where Gisella Vischini may publish in the future.

Co-authorship network of co-authors of Gisella Vischini

This figure shows the co-authorship network connecting the top 25 collaborators of Gisella Vischini. A scholar is included among the top collaborators of Gisella Vischini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisella Vischini. Gisella Vischini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capelli, Irene, Gisella Vischini, Vincenzo Donadio, et al.. (2025). The Role of Kidney Biopsy in Fabry Disease. Biomedicines. 13(4). 767–767. 1 indexed citations
2.
Manaresi, Elisabetta, Gisella Vischini, Michele Provenzano, et al.. (2025). Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature. The Lancet Infectious Diseases. 25(6). e360–e368. 1 indexed citations
3.
Capitoli, Giulia, Andrew Smith, Gisella Vischini, et al.. (2025). Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data. Kidney International Reports. 10(8). 2680–2689.
4.
Aiello, Valeria, Gisella Vischini, Marisa Santostefano, et al.. (2025). The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease. BMC Nephrology. 26(1). 77–77. 1 indexed citations
5.
Mignani, Renzo, et al.. (2025). The Fabry Nephropathy in Patients with N215S Variant. ˜The œNephron journals/Nephron journals. 149(10). 604–608. 1 indexed citations
6.
Maritati, Federica, Valeria Corradetti, Claudia Bini, et al.. (2024). “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy. Kidney International Reports. 9(4). 982–993. 7 indexed citations
7.
Donati, Gabriele, et al.. (2023). Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report. BMC Nephrology. 24(1). 204–204.
8.
Vischini, Gisella, et al.. (2023). Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvement. BMC Nephrology. 24(1). 381–381. 3 indexed citations
9.
Vischini, Gisella, et al.. (2022). Double glomerulopathies or two-faced janus? A challenging case in the COVID-19 era. Journal of Nephrology. 36(1). 225–228. 3 indexed citations
10.
Giglio, Andrea De, Marco Busutti, Gisella Vischini, et al.. (2022). Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience. Lung Cancer. 174. 91–96. 9 indexed citations
11.
Vischini, Gisella, et al.. (2021). Gemcitabine-Induced TMA: A Rare Side Effect Associated with High Mortality: A Case Report of Partial Response to Eculizumab. Journal of the American Society of Nephrology. 32(10S). 833–833.
12.
Cappagli, Virginia, Diego Moriconi, Angelo Giovanni Bonadio, et al.. (2020). Proteinuria is a late-onset adverse event in patients treated with cabozantinib. Journal of Endocrinological Investigation. 44(1). 95–103. 19 indexed citations
13.
Petricca, Luca, Maria Rita Gigante, Annamaria Paglionico, et al.. (2020). Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies. Frontiers in Medicine. 7. 553075–553075. 9 indexed citations
14.
Naticchia, Alessandro, et al.. (2019). Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report. Case Reports in Nephrology. 2019. 1–5. 1 indexed citations
15.
Vischini, Gisella, Meghan Kapp, Ferrin C. Wheeler, Laszlo Hopp, & Agnes B. Fogo. (2018). A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome. Human Pathology. 81. 229–234. 6 indexed citations
16.
Masola, Valentina, Gianluigi Zaza, Gloria Bellin, et al.. (2017). Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury. The FASEB Journal. 32(2). 742–756. 44 indexed citations
17.
Rollino, Cristiana, Gisella Vischini, & Rosanna Coppo. (2016). IgA nephropathy and infections. Journal of Nephrology. 29(4). 463–468. 73 indexed citations
18.
Carpia, Francesca La, Stefano Costanzi, Maurizio Martini, et al.. (2015). A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. European Journal of Human Genetics. 23(12). 1673–1678. 13 indexed citations
19.
Ferrannini, Michele, Claudio Cartoni, Roberto Palumbo, et al.. (2011). Management of peritoneal dialysis within a home care program for hematological malignancies: Concerns and perspectives illustrated by a case report. SHILAP Revista de lepidopterología. 17(2). 166–166. 1 indexed citations
20.
Niscola, Pasquale, Gisella Vischini, Andrea Tendas, et al.. (2011). Management of hematological malignancies in patients affected by renal failure. Expert Review of Anticancer Therapy. 11(3). 415–432. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Petrakis Breakdown of academic impact, for papers by G. Wild Breakdown of academic impact, for papers by Jakub Kucharz Breakdown of academic impact, for papers by Kinga Musiał Breakdown of academic impact, for papers by Gopalakrishnan Venkat‐Raman Breakdown of academic impact, for papers by Eujin Park Breakdown of academic impact, for papers by Deborah Kees‐Folts Breakdown of academic impact, for papers by Paul Trevillian Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Yıldız Okuturlar
Rankless by CCL
2026